GlassScriptPhysician profile
Arin Elsberry
NPI 1912538893
$3,828.41
in general payments reported to CMS, 2019-2025
39 companies · $705 in 2025
The $705 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $334 · 2022: $519 · 2023: $957 · 2024: $1,314 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,797 · Education: $179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,796.73 |
| Education | $178.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,080.96 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $481.78 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Astellas Pharma US INC | $362.91 | 2023-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $356.58 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Lilly USA, LLC | $240.87 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $150.82 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $135.26 | 2022-2025 | |
| Amgen INC. | $104.36 | 2022-2024 | Repatha, Otezla, Evenity |
| Sanofi-Aventis U.S. LLC | $79.45 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $74.60 | 2023-2025 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $72.69 | 2022 | |
| Dexcom, INC. | $68.27 | 2023-2024 | Dexcom G6 Transmitter |
| Nestle Healthcare Nutrition INC. | $60.05 | 2023 | |
| Aimmune Therapeutics, INC. | $50.79 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.15 | 2021-2022 |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arin Elsberry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.